Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Alcohol Use Disorder
NCT04964843Phase 2Withdrawn
- Sponsor
- Uniformed Services University of the Health Sciences
- Start
- Apr 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Change in total drinking days at 7 weeks and Change in drinks per drinking day at 7 weeks. Planned start Apr 2023; status: withdrawn.
02
Drugs
acetylcysteine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04964843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964843.